About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Breakfast With The Expert
16:04
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Optimizing Care for the Older Adolescent and Young Adult: Health Care Issues in Treating AYA Patients, Inclusion in Clinical Trials & Specific Toxicities
FEATURING
Nicolas Boissel
15 views
October 16, 2019
14:32
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
ALL Therapy for the Young Adults: Adoption of Pediatric Regimen, MRD as Predictor of Outcome, Adding Inotuzumab to Frontline Treatment & Next Steps
FEATURING
Wendy Stock
15 views
October 16, 2019
39:21
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
BCL-2 Inhibition in AML: High Effectiveness of Combination Therapy - Overview of Trials Combining Venetoclax and Targeted Agents (IDH, FLT3, MDM2 Inhibitors)
FEATURING
Marina Konopleva
134 views
November 5, 2019
12:03
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Histology of the Marginal Zone Lymphoma
FEATURING
Emanuele Zucca
43 views
October 18, 2019
21:31
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Marginal Zone Lymphoma: Role of PET, Antibiotic Therapy in Non-GI MALT, IO-Chemo vs. Radio in Localized Disease, Which Treatment in Disseminated Disease, How to Give RT?
FEATURING
Emanuele Zucca
47 views
November 20, 2019